 Biopharma leader Bristol-Myers Squibb posted solid Q3 results, despite competition from generic-drug makers for its popular cancer pill. The post Biopharma Bristol-Myers Unfazed By Generic Competition For Cancer Cash Cow appeared first on Investors Business Daily. 